Patrick R. O'Neil, EVP CLO & General Counsel at IONIS PHARMACEUTICALS INC (IONS), sold 41,650 shares at $51.46 ($2.1M) on 2023-12-26, disclosed to the SEC on 2023-12-28.
Scheduled sale ($2.1M) by EVP CLO & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.46 | 20,825 | $1.1M | 50.0% |
| 2 | $51.46 | 20,825 | $1.1M | 50.0% |
| Total | $51.46 avg | 41,650 | $2.1M | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $697K | — | Filing → |
| IONS | SELL | 2025-10-08 | $1.2M | — | Filing → |